In mice undergoing leptin glycopeptide treatment, several obesity-related pathologies (i.e., abnormal metabolic profile and liver histology as well as infertility) are normalized while unglycosylated leptin protein therapy does not show similar positive treatment outcomes (Kovalszky et al., 2010). Here, LEP is linked to obesity disorder.